HTG MOLECULAR DIAGNOSTICS (HTGM)

US40434H3021 - Common Stock

0.48  -0.12 (-20%)

After market: 0.4815 +0 (+0.31%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
6.21M6.37M8.91M8.55M19.20M
Cost Of Goods
4.87M4.57M4.09M3.99M8.91M
Gross Profit
1.35M1.79M4.81M4.56M10.29M
Operating Expenses
20.94M22.62M22.64M24.15M29.25M
Research and Development
6.47M6.78M6.09M6.08M10.57M
Selling, General, and Administrative Expenses
14.46M15.84M16.55M18.06M18.68M
Operating Income
-19.59M-20.83M-17.82M-19.59M-18.96M
Interest Income/Expense
-559.23K-762.37K-1.03M-770.00K-330.00K
Other Income/Expense
N/A8.33K0.0020.00KN/A
Non Recurring Items
N/A0.001.74M-520.00K0.00
Income Before Taxes
-20.14M-21.58M-17.12M-20.86M-19.29M
Income Tax
12.67K10.84K22.48K10.00K0.00
Net Income
-20.15M-21.59M-17.15M-20.87M-19.30M
EBITDA
-19.10M-20.24M-17.10M-18.24M-17.70M
 
Per Share Data
EPS Diluted Total Ops
-18.08-24.28-29.66-4.51-7.60
Non GAAP EPS
-18.15-25.59-32.88-52.56-93.60
 
Statistics
Gross Profit Margin
21.69%28.18%54.02%53.33%53.59%
Profit Margin
-324.28%-339.20%-192.49%-244.09%-100.52%
Operating Profit Margin
-315.21%-327.19%-200.11%-229.12%-98.75%

All data in USD

Charts